- Home
- SLNO vs RUN Comparison
SLNO vs RUN Comparison
Compare SLNO & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- RUN
- Stock Information
- Founded
- SLNO 1999
- RUN 2007
- Country
- SLNO United States
- RUN United States
- Employees
- SLNO N/A
- RUN N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RUN Industrial Machinery/Components
- Sector
- SLNO Health Care
- RUN Miscellaneous
- Exchange
- SLNO Nasdaq
- RUN Nasdaq
- Market Cap
- SLNO 1.9B
- RUN 2.2B
- IPO Year
- SLNO 2014
- RUN 2015
- Fundamental
- Price
- SLNO $49.17
- RUN $9.22
- Analyst Decision
- SLNO Strong Buy
- RUN Buy
- Analyst Count
- SLNO 6
- RUN 21
- Target Price
- SLNO $74.83
- RUN $19.81
- AVG Volume (30 Days)
- SLNO 567.7K
- RUN 8.6M
- Earning Date
- SLNO 03-05-2025
- RUN 02-19-2025
- Dividend Yield
- SLNO N/A
- RUN N/A
- EPS Growth
- SLNO N/A
- RUN N/A
- EPS
- SLNO N/A
- RUN N/A
- Revenue
- SLNO N/A
- RUN $2,035,817,000.00
- Revenue This Year
- SLNO N/A
- RUN N/A
- Revenue Next Year
- SLNO N/A
- RUN $12.89
- P/E Ratio
- SLNO N/A
- RUN N/A
- Revenue Growth
- SLNO N/A
- RUN N/A
- 52 Week Low
- SLNO $36.61
- RUN $8.95
- 52 Week High
- SLNO $60.92
- RUN $22.26
- Technical
- Relative Strength Index (RSI)
- SLNO 56.57
- RUN 38.76
- Support Level
- SLNO $45.44
- RUN $9.34
- Resistance Level
- SLNO $49.03
- RUN $9.71
- Average True Range (ATR)
- SLNO 2.36
- RUN 0.61
- MACD
- SLNO 0.66
- RUN -0.04
- Stochastic Oscillator
- SLNO 98.40
- RUN 9.37
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.